44 results on '"Nihoyannopoulos, Petros"'
Number of results to display per page
Search Results
2. Profile and management of hypertensive urgencies and emergencies in the emergency cardiology department of a tertiary hospital: a 12-month registry.
- Author
-
Fragoulis C, Dimitriadis K, Siafi E, Iliakis P, Kasiakogias A, Kalos T, Leontsinis I, Andrikou I, Konstantinidis D, Nihoyannopoulos P, Tsivgoulis G, Thomopoulos C, Tousoulis D, Muiesan ML, and Tsioufis KP
- Subjects
- Antihypertensive Agents therapeutic use, Emergencies, Humans, Registries, Tertiary Care Centers, Cardiology, Hypertension diagnosis, Hypertension epidemiology, Hypertension therapy
- Abstract
Aims: Currently there are scarce epidemiological data regarding prevalence, clinical phenotype, and therapy of hypertensive urgencies (HU) and emergencies (HE). The aim of this article was to record the prevalence, clinical characteristics, and management of patients with HU and HE assessed in an emergency department (ED) of a tertiary hospital., Methods and Results: The population consisted of patients presenting with HE and HU in the ED (acute increase in systolic blood pressure (BP) ≥ 180 mmHg and/or diastolic BP ≥120 mmHg with and without acute target organ damage, respectively). Of the 38 589 patients assessed in the ED during a 12-month period, 353 (0.91%) had HU and HE. There were 256 (72.5%) cases presented as HU and 97 (27.5%) as HE. Primary causes for both HU and HE were stress/anxiety (44.9%), increased salt intake (33.9%), and non-adherence to medication (16.2%). Patients with HU reported mainly dizziness/headache (46.8%) and chest pain (27.4%), whereas those with HE presented dyspnoea (67%), chest pain (30.2%), dizziness/headache (10.3%), and neurological disorders (8.2%). In HE, the underlying associated conditions were pulmonary oedema (58%), acute coronary syndrome (22.6%), and neurological disorders/stroke (7.2%). All HE cases were hospitalized and received intensive healthcare, including dialysis., Conclusion: This 1-year single-centre registry demonstrates a reasonable prevalence of HU and HE contributing to the high volume of visits to the ED. Stress, increased salt intake and non-adherence were main triggers of HE and HU. Dizziness and headache were the prevalent symptoms of HU patients while heart failure was the most common underlying disease in patients with HE., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2022
- Full Text
- View/download PDF
3. Adapting the role of handheld echocardiography during the COVID-19 pandemic: A practical guide.
- Author
-
Naderi H, Robinson S, Swaans MJ, Bual N, Cheung WS, Reid L, Shun-Shin M, Asaria P, Pabari P, Cole G, Kanaganayagam GS, Sutaria N, Bellamy M, Fox K, Nihoyannopoulos P, Petraco R, Al-Lamee R, Nijjer SS, Sen S, Ruparelia N, Baker C, Mikhail G, Malik I, Khamis R, Varnava A, Francis D, Mayet J, and Rana B
- Subjects
- Echocardiography, Humans, Pandemics, SARS-CoV-2, COVID-19, Cardiology
- Abstract
The COVID-19 pandemic has altered our approach to inpatient echocardiography delivery. There is now a greater focus to address key clinical questions likely to make an immediate impact in management, particularly during the period of widespread infection. Handheld echocardiography (HHE) can be used as a first-line assessment tool, limiting scanning time and exposure to high viral load. This article describes a potential role for HHE during a pandemic. We propose a protocol with a reporting template for a focused core dataset necessary in delivering an acute echocardiography service in the setting of a highly contagious disease, minimising risk to the operator. We cover the scenarios typically encountered in the acute cardiology setting and how an expert trained echocardiography team can identify such pathologies using a limited imaging format and include cardiac presentations encountered in those patients acutely unwell with COVID-19.
- Published
- 2021
- Full Text
- View/download PDF
4. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
- Author
-
Čelutkienė J, Pudil R, López-Fernández T, Grapsa J, Nihoyannopoulos P, Bergler-Klein J, Cohen-Solal A, Farmakis D, Tocchetti CG, von Haehling S, Barberis V, Flachskampf FA, Čeponienė I, Haegler-Laube E, Suter T, Lapinskas T, Prasad S, de Boer RA, Wechalekar K, Anker MS, Iakobishvili Z, Bucciarelli-Ducci C, Schulz-Menger J, Cosyns B, Gaemperli O, Belenkov Y, Hulot JS, Galderisi M, Lancellotti P, Bax J, Marwick TH, Chioncel O, Jaarsma T, Mullens W, Piepoli M, Thum T, Heymans S, Mueller C, Moura B, Ruschitzka F, Zamorano JL, Rosano G, Coats AJS, Asteggiano R, Seferovic P, Edvardsen T, and Lyon AR
- Subjects
- Antineoplastic Agents adverse effects, Female, Humans, Vascular Endothelial Growth Factor A, Cardiology, Heart Failure, Neoplasms drug therapy
- Abstract
Cardiovascular (CV) imaging is an important tool in baseline risk assessment and detection of CV disease in oncology patients receiving cardiotoxic cancer therapies. This position statement examines the role of echocardiography, cardiac magnetic resonance, nuclear cardiac imaging and computed tomography in the management of cancer patients. The Imaging and Cardio-Oncology Study Groups of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the ESC have evaluated the current evidence for the value of modern CV imaging in the cardio-oncology field. The most relevant echocardiographic parameters, including global longitudinal strain and three-dimensional ejection fraction, are proposed. The protocol for baseline pre-treatment evaluation and specific surveillance algorithms or pathways for anthracycline chemotherapy, HER2-targeted therapies such as trastuzumab, vascular endothelial growth factor tyrosine kinase inhibitors, BCr-Abl tyrosine kinase inhibitors, proteasome inhibitors and immune checkpoint inhibitors are presented. The indications for CV imaging after completion of oncology treatment are considered. The typical consequences of radiation therapy and the possibility of their identification in the long term are also summarized. Special populations are discussed including female survivors planning pregnancy, patients with carcinoid disease, patients with cardiac tumours and patients with right heart failure. Future directions and ongoing CV imaging research in cardio-oncology are discussed., (© 2020 European Society of Cardiology.)
- Published
- 2020
- Full Text
- View/download PDF
5. Imaging in patients with suspected acute heart failure: timeline approach position statement on behalf of the Heart Failure Association of the European Society of Cardiology.
- Author
-
Čelutkienė J, Lainscak M, Anderson L, Gayat E, Grapsa J, Harjola VP, Manka R, Nihoyannopoulos P, Filardi PP, Vrettou R, Anker SD, Filippatos G, Mebazaa A, Metra M, Piepoli M, Ruschitzka F, Zamorano JL, Rosano G, and Seferovic P
- Subjects
- Aftercare, Coronary Angiography, Europe, Humans, Magnetic Resonance Imaging, Patient Discharge, Societies, Medical, Tomography, X-Ray Computed, Cardiology standards, Heart Failure diagnostic imaging, Heart Failure therapy
- Abstract
Acute heart failure is one of the main diagnostic and therapeutic challenges in clinical practice due to a non-specific clinical manifestation and the urgent need for timely and tailored management at the same time. In this position statement, the Heart Failure Association aims to systematize the use of various imaging methods in accordance with the timeline of acute heart failure care proposed in the recent guidelines of the European Society of Cardiology. During the first hours of admission the point-of-care focused cardiac and lung ultrasound examination is an invaluable tool for rapid differential diagnosis of acute dyspnoea, which is highly feasible and relatively easy to learn. Several portable and stationary imaging modalities are being increasingly used for the evaluation of cardiac structure and function, haemodynamic and volume status, precipitating myocardial ischaemia or valvular abnormalities, and systemic and pulmonary congestion. This paper emphasizes the central role of the full echocardiographic examination in the identification of heart failure aetiology, severity of cardiac dysfunction, indications for specific heart failure therapy, and risk stratification. Correct evaluation of cardiac filling pressures and accurate prognostication may help to prevent unscheduled short-term readmission. Alternative advanced imaging modalities should be considered to assist patient management in the pre- and post-discharge phase, including cardiac magnetic resonance, computed tomography, nuclear studies, and coronary angiography. The Heart Failure Association addresses this paper to the wide spectrum of acute care and heart failure specialists, highlighting the value of all available imaging techniques at specific stages and in common clinical scenarios of acute heart failure., (© 2019 The Authors. European Journal of Heart Failure © 2019 European Society of Cardiology.)
- Published
- 2020
- Full Text
- View/download PDF
6. Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.
- Author
-
Čelutkienė J, Plymen CM, Flachskampf FA, de Boer RA, Grapsa J, Manka R, Anderson L, Garbi M, Barberis V, Filardi PP, Gargiulo P, Zamorano JL, Lainscak M, Seferovic P, Ruschitzka F, Rosano GMC, and Nihoyannopoulos P
- Subjects
- Europe, Exercise Test, Humans, Cardiac Imaging Techniques methods, Cardiology, Consensus, Heart Failure diagnosis, Societies, Medical
- Abstract
Myriad advances in all fields of cardiac imaging have stimulated and reflected new understanding of cardiac performance, myocardial damage and the mechanisms of heart failure. In this paper, the Heart Failure Association assesses the potential usefulness of innovative imaging modalities in enabling more precise diagnostic and prognostic evaluation, as well as in guiding treatment strategies. Many new methods have gradually penetrated clinical practice and are on their way to becoming a part of routine evaluation. This paper focuses on myocardial deformation and three-dimensional ultrasound imaging; stress tests for the evaluation of contractile and filling function; the progress of magnetic resonance techniques; molecular imaging and other sound innovations. The Heart Failure Association aims to highlight the ways in which paradigms have shifted in several areas of cardiac assessment. These include reassessing of the simplified concept of ejection fraction and implementation of the new parameters of cardiac performance applicable to all heart failure phenotypes; switching from two-dimensional to more accurate and reproducible three-dimensional ultrasound volumetric evaluation; greater tissue characterization via recently developed magnetic resonance modalities; moving from assessing cardiac function and congestion at rest to assessing it during stress; from invasive to novel non-invasive hybrid techniques depicting coronary anatomy and myocardial perfusion; as well as from morphometry to the imaging of pathophysiologic processes such as inflammation and apoptosis. This position paper examines the specific benefits of imaging innovations for practitioners dealing with heart failure aetiology, risk stratification and monitoring, and, in addition, for scientists involved in the development of future research., (© 2018 The Authors. European Journal of Heart Failure © 2018 European Society of Cardiology.)
- Published
- 2018
- Full Text
- View/download PDF
7. Power of resting echocardiographic measurements to classify pulmonary hypertension patients according to European society of cardiology exercise testing risk stratification cut-offs.
- Author
-
Rehman MB, Garcia R, Christiaens L, Larrieu-Ardilouze E, Howard LS, and Nihoyannopoulos P
- Subjects
- Adult, Aged, Aged, 80 and over, Cardiology classification, Echocardiography classification, Europe epidemiology, Exercise Test classification, Female, Humans, Hypertension, Pulmonary classification, Hypertension, Pulmonary epidemiology, Male, Middle Aged, Prospective Studies, Risk Assessment, Cardiology methods, Echocardiography methods, Exercise Test methods, Hypertension, Pulmonary diagnostic imaging, Rest, Societies, Medical classification
- Abstract
Background: Right ventricular function is the major determinant of morbidity and mortality in pulmonary arterial hypertension (PAH). The ESC risk assessment strategy for PAH is based on clinical status, exercise testing, NTproBNP, imaging and haemodynamics but does not include right ventricular function. Our aims were to test the power of resting echocardiographic measurements to classify PAH patients according to ESC exercise testing risk stratification cut-offs and to determine if the classification power of echocardiographic parameters varied in chronic thrombo-embolic pulmonary hypertension (CTEPH)., Methods: We prospectively and consecutively recruited 46 PAH patients and 42 CTEPH patients referred for cardio-pulmonary exercise testing and comprehensive transthoracic echocardiography. Exercise testing parameters analyzed were peak oxygen consumption, percentage of predicted maximal oxygen consumption and the slope of ventilation against carbon dioxide production. Receiver operator characteristic curves were used to determine the optimal diagnostic cut-off values of echocardiographic parameters for classifying the patients in intermediate or high risk category according to exercise testing., Results: Measurements of right ventricular systolic function were the best for classifying in PAH (area under the curve 0.815 to 0.935). Measurements of right ventricular pressure overload (0.810 to 0.909) were optimal for classifying according to exercise testing in CTEPH. Measurements of left ventricular function were of no use in either group., Conclusions: Measurements of right ventricular systolic function can classify according to exercise testing risk stratification cut-offs in PAH. However, this is not the case in CTEPH where pressure overload, rather than right ventricular function seems to be linked to exercise performance., (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
8. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
- Author
-
Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GY, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM, Zamorano JL, Aboyans V, Achenbach S, Agewall S, Badimon L, Barón-Esquivias G, Baumgartner H, Bax JJ, Bueno H, Carerj S, Dean V, Erol Ç, Fitzsimons D, Gaemperli O, Kirchhof P, Kolh P, Lancellotti P, Lip GY, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Roffi M, Torbicki A, Vaz Carneiro A, and Windecker S
- Subjects
- Antineoplastic Agents therapeutic use, Cardiotoxicity, Congresses as Topic, Europe, Humans, Antineoplastic Agents adverse effects, Cardiology, Heart Diseases chemically induced, Neoplasms drug therapy, Practice Guidelines as Topic, Societies, Medical
- Published
- 2017
- Full Text
- View/download PDF
9. [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure].
- Author
-
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, and van der Meer P
- Subjects
- Acute Disease, Chronic Disease, Europe, Female, Heart Failure therapy, Humans, Male, Cardiology, Heart Failure diagnosis, Societies, Medical
- Published
- 2016
- Full Text
- View/download PDF
10. J.R.T.C. Roelandt (November 12, 1938-August 31, 2014).
- Author
-
Lancellotti P, Habib G, Badano L, Fraser A, Nihoyannopoulos P, Pinto F, Zamorano JL, Distante A, Founder E, and Maurer G
- Subjects
- Europe, History, 20th Century, History, 21st Century, Cardiology history, Echocardiography history
- Published
- 2014
- Full Text
- View/download PDF
11. [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy].
- Author
-
Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, and Watkins H
- Subjects
- Europe, Humans, Societies, Medical, Cardiology standards, Cardiomyopathy, Hypertrophic diagnosis, Cardiomyopathy, Hypertrophic therapy, Practice Guidelines as Topic
- Published
- 2014
- Full Text
- View/download PDF
12. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography.
- Author
-
Lang RM, Badano LP, Tsang W, Adams DH, Agricola E, Buck T, Faletra FF, Franke A, Hung J, de Isla LP, Kamp O, Kasprzak JD, Lancellotti P, Marwick TH, McCulloch ML, Monaghan MJ, Nihoyannopoulos P, Pandian NG, Pellikka PA, Pepi M, Roberson DA, Shernan SK, Shirali GS, Sugeng L, Ten Cate FJ, Vannan MA, Zamorano JL, and Zoghbi WA
- Subjects
- Algorithms, Echocardiography, Doppler methods, Europe, Heart Valves pathology, Heart Ventricles pathology, Humans, Societies, Medical, Stroke Volume, United States, Ventricular Function, Left, Cardiology standards, Echocardiography, Doppler standards, Echocardiography, Three-Dimensional standards, Heart Valves diagnostic imaging, Heart Ventricles diagnostic imaging
- Published
- 2012
- Full Text
- View/download PDF
13. Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease
- Author
-
Ikonomidis, Ignatios, Lekakis, John, Vamvakou, Georgia, Andreotti, Felicita, and Nihoyannopoulos, Petros
- Subjects
Smoking -- Care and treatment ,Coronary heart disease -- Care and treatment ,Medical colleges ,Thrombin ,Cardiology ,Endothelium ,Aspirin ,Health - Abstract
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ahj.2004.08.030 Byline: Ignatios Ikonomidis (b), John Lekakis (b), Georgia Vamvakou (b), Felicita Andreotti (a), Petros Nihoyannopoulos (a) Abstract: Smoking is associated with endothelial dysfunction. Cytokines released by injured endothelium promote vascular interactions with leukocytes and platelets. We investigated whether (a) cigarette smoking is linked to increased cytokine production, which may mediate platelet activation and thrombin generation in chronic coronary artery disease (CAD), and (b) aspirin treatment inhibits smoking-related changes on cytokines, platelets, and thrombin. Author Affiliation: (a) Imperial College School of Medicine, National Heart and Lung Institute, Cardiology Department, Hammersmith Hospital, London, United Kingdom (b) Department of Clinical Therapeutics, University of Athens, Alexandra Hospital, Athens, Greece Article History: Received 27 May 2004; Accepted 24 August 2004 Article Note: (footnote) This work was supported by Hammersmith Hospital grant RC/259., There is no conflict of interest for any of the contributing authors.
- Published
- 2005
14. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure [Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica]
- Author
-
Ponikowski, Autores/Miembros del Grupo de Trabajo: Piotr, Voors, Adriaan A., Anker, Stefan D., Bueno, Héctor, Cleland, John G. F., Coats, Andrew J. S., Falk, Volkmar, González-Juanatey, José Ramón, Harjola, Veli-Pekka, Jankowska, Ewa A., Jessup, Mariell, Linde, Cecilia, Nihoyannopoulos, Petros, Parissis, John T., Pieske, Burkert, Riley, Jillian P., Rosano, Giuseppe M. C., Ruilope, Luis M., Ruschitzka, Frank, Rutten, Frans H., van der Meer, Peter, Filippatos, Revisores del documento: Gerasimos, Mcmurray, John J. V., Aboyans, Victor, Achenbach, Stephan, Agewall, Stefan, Al-Attar, Nawwar, James Atherton, John, Bauersachs, Johann, Camm, A. John, Carerj, Scipione, Ceconi, Claudio, Coca, Antonio, Elliott, Perry, Erol, Çetin, Ezekowitz, Justin, Fernández-Golfín, Covadonga, Fitzsimons, Donna, Guazzi, Marco, Guenoun, Maxime, Hasenfuss, Gerd, Hindricks, Gerhard, Hoes, Arno W., Iung, Bernard, Jaarsma, Tiny, Kirchhof, Paulus, Knuuti, Juhani, Kolh, Philippe, Konstantinides, Stavros, Lainscak, Mitja, Lancellotti, Patrizio, Lip, Gregory Y. H., Maisano, Francesco, Mueller, Christian, Petrie, Mark C., Piepoli, Massimo F., Priori, Silvia G., Torbicki, Adam, Tsutsui, Hiroyuki, van Veldhuisen, Dirk J., Windecker, Stephan, Yancy, Clyde, and Zamorano, José Luis
- Subjects
Cardiology, Cardiovascular Medicine ,Cardiology ,Cardiovascular Medicine ,NO - Published
- 2016
15. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)
- Author
-
Priori, Silvia G, Blomstrom Lundqvist, Carina, Mazzanti, Andrea, Bloma, Nico, Borggrefe, Martin, Camm, John, Elliott, Perry Mark, Fitzsimons, Donna, Hatala, Robert, Hindricks, Gerhard, Kirchhof, Paulus, Kjeldsen, Keld, Kuck, Karl Heinz, Hernandez Madrid, Antonio, Nikolaou, Nikolaos, Norekval, Tone M., Spaulding, Christian, Van Veldhuisen, Dirk J., Kolh, Philippe, Lip, Gregory Y. H., Agewall, Stefan, Barón Esquivias, Gonzalo, Boriani, Giuseppe, Budts, Werner, Bueno, Héctor, Capodanno, Davide, Carerj, Scipione, Crespo Leiro, Maria G., Czerny, Martin, Deaton, Christi, Dobrev, Dobromir, Erol, Çetin, Galderisi, Maurizio, Gorenek, Bulent, Kriebel, Thomas, Lambiase, Pier, Lancellotti, Patrizio, Lane, Deirdre A., Lang, Irene, Manolis, Athanasios J., Morais, Joao, Moreno, Javier, Piepoli, Massimo F., Rutten, Frans H., Sredniawa, Beata, Zamorano, Jose Luis, Zannad, Faiez, Aboyans, Victor, Achenbach, Stephan, Badimon, Lina, Baumgartner, Helmut, Bax, Jeroen J., Dean, Veronica, Gaemperli, Oliver, Nihoyannopoulos, Petros, Ponikowski, Piotr, Roffi, Marco, Torbicki, Adam, Vaz Carneiro, Antonio, Windecker, Stephan, Piruzyan, Armen, Roithinger, Franz Xaver, Mairesse, Georges H., Goronja, Boris, Shalganov, Tchavdar, Puljević, Davor, Antoniades, Loizos, Kautzner, Josef, Larsen, Jacob Moesgaard, Aboulmaaty, Mervat, Kampus, Priit, Hedman, Antti, Kamcevska Dobrkovic, Lidija, Piot, Olivier, Etsadashvili, Kakhaber, Eckardt, Lars, Deftereos, Spyridon, Gellér, László, Gizurarson, Sigfús, Keane, David, Haim, Moti, Della Bella, Paolo, Abdrakhmanov, Ayan, Mirrakhimov, Aibek, Kalejs, Oskars, Ben Lamin, Hisham, Marinskis, Germanas, Groben, Laurent, Sammut, Mark, Raducan, Aurica, Chaib, Ali, Tande, Pål Morten, Lenarczyk, Radoslaw, Morgado, Francisco Bello, Vatasescu, Radu, Mikhaylov, Evgeny N., Hlivak, Peter, Arenal, Angel, Jensen Urstad, Mats, Sticherling, Christian, Zeppenfeld, Katja, Chettaoui, Rafik, Demir, Mesut, Duncan, Edward, Parkhomenko, Alexander, Priori, Silvia G, Blomström Lundqvist, Carina, Mazzanti, Andrea, Bloma, Nico, Borggrefe, Martin, Camm, John, Elliott, Perry Mark, Fitzsimons, Donna, Hatala, Robert, Hindricks, Gerhard, Kirchhof, Paulu, Kjeldsen, Keld, Kuck, Karl Heinz, Hernandez Madrid, Antonio, Nikolaou, Nikolao, Norekvål, Tone M., Spaulding, Christian, Van Veldhuisen, Dirk J., Kolh, Philippe, Lip, Gregory Y. H., Agewall, Stefan, Barón Esquivias, Gonzalo, Boriani, Giuseppe, Budts, Werner, Bueno, Héctor, Capodanno, Davide, Carerj, Scipione, Crespo Leiro, Maria G., Czerny, Martin, Deaton, Christi, Dobrev, Dobromir, Erol, Çetin, Galderisi, Maurizio, Gorenek, Bulent, Kriebel, Thoma, Lambiase, Pier, Lancellotti, Patrizio, Lane, Deirdre A., Lang, Irene, Manolis, Athanasios J., Morais, Joao, Moreno, Javier, Piepoli, Massimo F., Rutten, Frans H., Sredniawa, Beata, Zamorano, Jose L., and Zannad, Faiez
- Subjects
medicine.medical_treatment ,Left ,Myocardial Infarction ,Coronary Artery Disease ,Arrhythmias ,Amiodarone ,Cardiovascular ,Ventricular Dysfunction, Left ,Pregnancy ,Implantable cardioverter defibrillator ,Myocardial infarction ,Child ,Sleep Apnea, Obstructive ,Terminal Care ,Implantable cardioverter-defibrillator ,Defibrillators, Implantable ,Primary Prevention ,Practice Guideline ,Acute Disease ,Ventricular arrhythmia ,Catheter Ablation ,Stable coronary artery disease ,Drug Therapy, Combination ,Acute coronary syndrome ,Autopsy ,Implantable ,Cardiology and Cardiovascular Medicine ,Cardiomyopathies ,Cardiac ,Human ,Sports ,Heart Defects, Congenital ,medicine.medical_specialty ,Sleep Apnea ,Cardiotonic Agents ,Electric Countershock ,Heart failure ,Guidelines ,Risk Assessment ,Drug Therapy ,Physiology (medical) ,Humans ,Emergency Treatment ,Congenital heart disease ,Aged ,Cardiac arrhythmia ,medicine.disease ,Valvular heart disease ,Pregnancy Complications ,Sudden cardiac death ,Death, Sudden, Cardiac ,Early Diagnosis ,Medizin ,Heart Valve Diseases ,Guideline ,Coronary artery disease ,Cardiac Resynchronization Therapy ,Defibrillator ,Congenital ,Risk Factors ,Tachycardia ,Ventricular Dysfunction ,Cardiac resynchronization therapy ,Cardiomyopathy ,Resuscitation ,Anti-Arrhythmia Agents ,Arrhythmias, Cardiac ,Defibrillators ,Female ,Heart Transplantation ,Mental Disorders ,Myocarditis ,Nervous System Diseases ,Out-of-Hospital Cardiac Arrest ,Pregnancy Complications, Cardiovascular ,Quality of Life ,Stroke Volume ,Heart Defects ,Atrial fibrillation ,Combined Modality Therapy ,Death ,Treatment Outcome ,Anti-Arrhythmia Agent ,Combination ,Cardiology ,medicine.drug ,Catheter ablation ,Acute coronary syndrome † Cardiac resynchronization therapy † Cardiomyopathy † Congenital heart disease † Defibrillator † Guidelines † Heart failure † Implantable cardioverter defibrillator † Myocardial infarction † Resuscitation † Stable coronary artery disease † Sudden cardiac death † Tachycardia † Valvular heart disease † Ventricular arrhythmia ,Internal medicine ,medicine ,Journal Article ,cardiovascular diseases ,business.industry ,Obstructive ,Risk Factor ,Sudden ,business - Abstract
ACC : American College of Cardiology ACE : angiotensin-converting enzyme ACS : acute coronary syndrome AF : atrial fibrillation AGNES : Arrhythmia Genetics in the Netherlands AHA : American Heart Association AMIOVIRT : AMIOdarone Versus Implantable cardioverter-defibrillator
- Published
- 2015
16. The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association.
- Author
-
Ikonomidis, Ignatios, Aboyans, Victor, Blacher, Jacque, Brodmann, Marianne, Brutsaert, Dirk L., Chirinos, Julio A., De Carlo, Marco, Delgado, Victoria, Lancellotti, Patrizio, Lekakis, John, Mohty, Dania, Nihoyannopoulos, Petros, Parissis, John, Rizzoni, Damiano, Ruschitzka, Frank, Seferovic, Petar, Stabile, Eugenio, Tousoulis, Dimitrios, Vinereanu, Dragos, and Vlachopoulos, Charalambos
- Subjects
HEART diseases ,HEART failure ,HEART valve diseases ,TEAMS in the workplace ,CARDIOLOGY ,AORTA - Abstract
Ventricular-arterial coupling (VAC) plays a major role in the physiology of cardiac and aortic mechanics, as well as in the pathophysiology of cardiac disease. VAC assessment possesses independent diagnostic and prognostic value and may be used to refine riskstratification and monitor therapeutic interventions. Traditionally, VAC is assessed by the non-invasive measurement of the ratio of arterial (Ea) to ventricular end-systolic elastance (Ees). With disease progression, both Ea and Ees may become abnormal and the Ea/Ees ratio may approximate its normal values. Therefore, the measurement of each component of this ratio or of novel more sensitive markers of myocardial (e.g. global longitudinal strain) and arterial function (e.g. pulse wave velocity) may better characterize VAC. In valvular heart disease, systemic arterial compliance and valvulo-arterial impedance have an established diagnostic and prognostic value and may monitor the effects of valve replacement on vascular and cardiac function. Treatment guided to improve VAC through improvement of both or each one of its components may delay incidence of heart failure and possibly improve prognosis in heart failure. In this consensus document, we describe the pathophysiology, the methods of assessment as well as the clinical implications of VAC in cardiac diseases and heart failure. Finally, we focus on interventions that may improve VAC and thus modify prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
17. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)
- Author
-
Kristensen, Steen Dalby, Knuuti, Juhani, Saraste, Antti, Anker, Stefan, Bøtker, Hans Erik, De Hert, Stefan, Ford, Ian, Gonzalez-Juanatey, Jose Ramón, Gorenek, Bulent, Heyndrickx, Guy Robert, Hoeft, Andreas, Huber, Kurt, Iung, Bernard, Kjeldsen, Keld Per, Longrois, Dan, Lüscher, Thomas F, Pierard, Luc, Pocock, Stuart, Price, Susanna, Roffi, Marco, Sirnes, Per Anton, Sousa-Uva, Miguel, Voudris, Vasilis, Funck-Brentano, Christian, Zamorano, Jose Luis, Achenbach, Stephan, Baumgartner, Helmut, Bax, Jeroen J, Bueno, Héctor, Dean, Veronica, Deaton, Christi, Erol, Cetin, Fagard, Robert, Ferrari, Roberto, Hasdai, David, Hoes, Arno W, Kirchhof, Paulus, Kolh, Philippe, Lancellotti, Patrizio, Linhart, Ales, Nihoyannopoulos, Petros, Piepoli, Massimo F, Ponikowski, Piotr, Tamargo, Juan Luis, Tendera, Michal, Torbicki, Adam, Wijns, William, Joergensen, Torben, University of Zurich, Kristensen, Steen Dalby, Kristensen, Sd, DE ROBERTIS, Edoardo, and Anesthesiology
- Subjects
medicine.medical_treatment ,Arrhythmias ,Coronary artery disease ,Beta-blockers ,Anesthesiology ,Medicine ,Cerebrovascular disease ,Pre-operative cardiac risk assessment ,Societies, Medical ,Pre-operative coronary artery revascularization ,Ejection fraction ,Disease Management ,Atrial fibrillation ,Post-operative cardiac surveillance ,Implantable cardioverter-defibrillator ,Cardiac surgery ,Europe ,Anaesthesiology ,Anti-thrombotic therapy ,Guidelines ,Heart failure ,Non-cardiac surgery ,Perioperative cardiac management ,Pre-operative cardiac testing ,Pulmonary disease ,Renal disease ,Valvular disease ,Cardiovascular Diseases ,Practice Guidelines as Topic ,cardiovascular system ,Cardiology ,10209 Clinic for Cardiology ,Cardiology and Cardiovascular Medicine ,medicine.medical_specialty ,Advisory Committees ,610 Medicine & health ,2705 Cardiology and Cardiovascular Medicine ,NO ,Internal medicine ,Humans ,cardiovascular diseases ,ta3126 ,business.industry ,Percutaneous coronary intervention ,ta3121 ,medicine.disease ,Clinical medicine ,business ,Kidney disease - Abstract
AAA : abdominal aortic aneurysm ACEI : angiotensin converting enzyme inhibitor ACS : acute coronary syndromes AF : atrial fibrillation AKI : acute kidney injury AKIN : Acute Kidney Injury Network ARB : angiotensin receptor blocker ASA : American Society of Anesthesiologists b.i.d. : bis in diem (twice daily) BBSA : Beta-Blocker in Spinal Anesthesia BMS : bare-metal stent BNP : B-type natriuretic peptide bpm : beats per minute CABG : coronary artery bypass graft CAD : coronary artery disease CARP : Coronary Artery Revascularization Prophylaxis CAS : carotid artery stenting CASS : Coronary Artery Surgery Study CEA : carotid endarterectomy CHA2DS2-VASc : cardiac failure, hypertension, age ≥75 (doubled), diabetes, stroke (doubled)-vascular disease, age 65–74 and sex category (female) CI : confidence interval CI-AKI : contrast-induced acute kidney injury CKD : chronic kidney disease CKD-EPI : Chronic Kidney Disease Epidemiology Collaboration Cmax : maximum concentration CMR : cardiovascular magnetic resonance COPD : chronic obstructive pulmonary disease CPG : Committee for Practice Guidelines CPX/CPET : cardiopulmonary exercise test CRP : C-reactive protein CRT : cardiac resynchronization therapy CRT-D : cardiac resynchronization therapy defibrillator CT : computed tomography cTnI : cardiac troponin I cTnT : cardiac troponin T CVD : cardiovascular disease CYP3a4 : cytochrome P3a4 enzyme DAPT : dual anti-platelet therapy DECREASE : Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography DES : drug-eluting stent DIPOM : DIabetic Post-Operative Mortality and Morbidity DSE : dobutamine stress echocardiography ECG : electrocardiography/electrocardiographically/electrocardiogram eGFR : estimated glomerular filtration rate ESA : European Society of Anaesthesiology ESC : European Society of Cardiology EVAR : endovascular abdominal aortic aneurysm repair FEV1 : Forced expiratory volume in 1 second HbA1c : glycosylated haemoglobin HF-PEF : heart failure with preserved left ventricular ejection fraction HF-REF : heart failure with reduced left ventricular ejection fraction ICD : implantable cardioverter defibrillator ICU : intensive care unit IHD : ischaemic heart disease INR : international normalized ratio IOCM : iso-osmolar contrast medium KDIGO : Kidney Disease: Improving Global Outcomes LMWH : low molecular weight heparin LOCM : low-osmolar contrast medium LV : left ventricular LVEF : left ventricular ejection fraction MaVS : Metoprolol after Vascular Surgery MDRD : Modification of Diet in Renal Disease MET : metabolic equivalent MRI : magnetic resonance imaging NHS : National Health Service NOAC : non-vitamin K oral anticoagulant NSQIP : National Surgical Quality Improvement Program NSTE-ACS : non-ST-elevation acute coronary syndromes NT-proBNP : N-terminal pro-BNP O2 : oxygen OHS : obesity hypoventilation syndrome OR : odds ratio P gp : platelet glycoprotein PAC : pulmonary artery catheter PAD : peripheral artery disease PAH : pulmonary artery hypertension PCC : prothrombin complex concentrate PCI : percutaneous coronary intervention POBBLE : Peri-Operative Beta-BLockadE POISE : Peri-Operative ISchemic Evaluation POISE-2 : Peri-Operative ISchemic Evaluation 2 q.d. : quaque die (once daily) RIFLE : Risk, Injury, Failure, Loss, End-stage renal disease SPECT : single photon emission computed tomography SVT : supraventricular tachycardia SYNTAX : Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery TAVI : transcatheter aortic valve implantation TdP : torsades de pointes TIA : transient ischaemic attack TOE : transoesophageal echocardiography TOD : transoesophageal doppler TTE : transthoracic echocardiography UFH : unfractionated heparin VATS : video-assisted thoracic surgery VHD : valvular heart disease VISION : Vascular Events In Noncardiac Surgery Patients Cohort Evaluation VKA : vitamin K antagonist VPB : ventricular premature beat VT : ventricular tachycardia Guidelines summarize and evaluate all available evidence, at the time of the writing process, on a particular issue with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition, taking into account the impact on outcome, as well as the risk–benefit ratio of particular diagnostic …
- Published
- 2014
18. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
- Author
-
Konstantinides, Stavros V., Torbicki, Adam, Agnelli, Giancarlo, Danchin, Nicolas, Fitzmaurice, David, Galiè, Nazzareno, Gibbs, J. Simon R., Huisman, Menno V., Humbert, Marc, Kucher, Nils, Lang, Irene, Lankeit, Mareike, Lekakis, John, Maack, Christoph, Mayer, Eckhard, Meneveau, Nicolas, Perrier, Arnaud, Pruszczyk, Piotr, Rasmussen, Lars H., Schindler, Thomas H., Svitil, Pavel, Noordegraaf, Anton Vonk, Zamorano, Jose Luis, Zompatori, Maurizio, Achenbach, Stephan, Baumgartner, Helmut, Bax, Jeroen J., Bueno, Hector, Dean, Veronica, Deaton, Christi, Erol, Çetin, Fagard, Robert, Ferrari, Roberto, Hasdai, David, Hoes, Arno, Kirchhof, Paulus, Knuuti, Juhani, Kolh, Philippe, Lancellotti, Patrizio, Linhart, Ales, Nihoyannopoulos, Petros, Piepoli, Massimo F., Ponikowski, Piotr, Sirnes, Per Anton, Tamargo, Juan Luis, Tendera, Michal, Wijns, William, Windecker, Stephan, Jimenez, David, Ageno, Walter, Agewall, Stefan, Asteggiano, Riccardo, Bauersachs, Rupert, Becattini, Cecilia, Bounameaux, Henri, Büller, Harry R., Davos, Constantinos H., Geersing, Geert-Jan, Sanchez, Miguel Angel Gómez, Hendriks, Jeroen, Kilickap, Mustafa, Mareev, Viacheslav, Monreal, Manuel, Morais, Joao, Popescu, Bogdan A., Sanchez, Olivier, Spyropoulos, Alex C, Fedele, Francesco, Konstantinides S, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman M, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M., Torbicki A1, and Svítil P
- Subjects
Vitamin K ,Vasodilator Agents ,Administration, Oral ,Chest pain ,Diagnosis ,Dyspnoea ,Guidelines ,Heart failure ,Hypotension ,Pulmonary embolism ,Shock ,Thrombolysis ,Treatment-Anticoagulation ,Venousthrombosis ,Algorithms ,Anticoagulants ,Biomarkers ,Chronic Disease ,Clinical Laboratory Techniques ,Diagnostic Imaging ,Embolectomy ,Endovascular Procedures ,Female ,Fibrin Fibrinogen Degradation Products ,Fibrinolytic Agents ,Heart Failure ,Home Care Services ,Humans ,Hypertension, Pulmonary ,Long-Term Care ,Neoplasms ,Pregnancy ,Pregnancy Complications, Cardiovascular ,Prognosis ,Pulmonary Embolism ,Risk Factors ,Vasoconstrictor Agents ,Cardiology and Cardiovascular Medicine ,Cardiovascular ,Societies, Medical ,General Medicine ,Pulmonary ,Thrombosis ,Europe ,Venous thrombosis ,medicine.vein ,Practice Guidelines as Topic ,Administration ,Hypertension ,Cardiology ,Apixaban ,Radiology ,medicine.drug ,Oral ,medicine.medical_specialty ,pumonary hypertension ,medicine.drug_class ,MEDLINE ,Low molecular weight heparin ,610 Medicine & health ,Inferior vena cava ,Text mining ,Internal medicine ,medicine ,Intensive care medicine ,business.industry ,medicine.disease ,Pulmonary hypertension ,Pregnancy Complications ,business - Abstract
ACS : acute coronary syndrome AMPLIFY : Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-line Therapy aPTT : activated partial thromboplastin time b.i.d. : bis in diem (twice daily) b.p.m. : beats per minute BNP : brain natriuretic peptide BP : blood pressure CI : confidence interval CO : cardiac output COPD : chronic obstructive pulmonary disease CPG : Committee for Practice Guidelines CRNM : clinically relevant non-major CT : computed tomographic/tomogram CTEPH : chronic thromboembolic pulmonary hypertension CUS : compression venous ultrasonography DSA : digital subtraction angiography DVT : deep vein thrombosis ELISA : enzyme-linked immunosorbent assay ESC : European Society of Cardiology H-FABP : heart-type fatty acid-binding protein HIT : heparin-induced thrombocytopenia HR : hazard ratio ICOPER : International Cooperative Pulmonary Embolism Registry ICRP : International Commission on Radiological Protection INR : international normalized ratio iPAH : idiopathic pulmonary arterial hypertension IVC : inferior vena cava LMWH : low molecular weight heparin LV : left ventricle/left ventricular MDCT : multi-detector computed tomographic (angiography) MRA : magnetic resonance angiography NGAL : neutrophil gelatinase-associated lipocalin NOAC(s) : Non-vitamin K-dependent new oral anticoagulant(s) NT-proBNP : N-terminal pro-brain natriuretic peptide o.d. : omni die (every day) OR : odds ratio PAH : pulmonary arterial hypertension PE : pulmonary embolism PEA : pulmonary endarterectomy PEITHO : Pulmonary EmbolIsm THrOmbolysis trial PESI : pulmonary embolism severity index PH : pulmonary hypertension PIOPED : Prospective Investigation On Pulmonary Embolism Diagnosis PVR : pulmonary vascular resistance RIETE : Registro Informatizado de la Enfermedad Thromboembolica venosa RR : relative risk rtPA : recombinant tissue plasminogen activator RV : right ventricle/ventricular SPECT : single photon emission computed tomography sPESI : simplified pulmonary embolism severity index TAPSE : tricuspid annulus plane systolic excursion Tc : technetium TOE : transoesophageal echocardiography TTR : time in therapeutic range TV : tricuspid valve UFH : unfractionated heparin V/Q scan : ventilation–perfusion scintigraphy VKA : vitamin K antagonist(s) VTE : venous thromboembolism Guidelines summarize and evaluate all available evidence at the time of the writing process, on a particular issue with the aim of assisting health professionals in selecting the best management strategies for an individual patient, with a given condition, taking into account the impact on outcome, as well as the risk-benefit-ratio of particular diagnostic or therapeutic means. Guidelines and recommendations should help the health professionals to make decisions in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate. A great number of Guidelines have …
- Published
- 2014
19. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology
- Author
-
Montalescot, Gilles, Sechtem, Udo, Achenbach, Stephan, Andreotti, Felicita, Arden, Chris, Budaj, Andrzej, Bugiardini, Raffaele, Crea, Filippo, Cuisset, Thomas, Di Mario, Carlo, Ferreira, J Rafael, Gersh, Bernard J, Gitt, Anselm K, Hulot, Jean-Sebastien, Marx, Nikolaus, Opie, Lionel H, Pfisterer, Matthias, Prescott, Eva, Ruschitzka, Frank, Sabaté, Manel, Senior, Roxy, Taggart, David Paul, van der Wall, Ernst E, Vrints, Christiaan J M, Zamorano, Jose Luis, Baumgartner, Helmut, Bax, Jeroen J, Bueno, Héctor, Dean, Veronica, Deaton, Christi, Erol, Cetin, Fagard, Robert, Ferrari, Roberto, Hasdai, David, Hoes, Arno W, Kirchhof, Paulus, Knuuti, Juhani, Kolh, Philippe, Lancellotti, Patrizio, Linhart, Ales, Nihoyannopoulos, Petros, Piepoli, Massimo F, Ponikowski, Piotr, Sirnes, Per Anton, Tamargo, Juan Luis, Tendera, Michal, Torbicki, Adam, Wijns, William, Windecker, Stephan, Valgimigli, Marco, Claeys, Marc J, Donner-Banzhoff, Norbert, Frank, Herbert, Funck-Brentano, Christian, Gaemperli, Oliver, Gonzalez-Juanatey, José R, Hamilos, Michalis, Husted, Steen, James, Stefan K, Kervinen, Kari, Kristensen, Steen Dalby, Maggioni, Aldo Pietro, Pries, Axel R, Romeo, Francesco, Rydén, Lars, Simoons, Maarten L, Steg, Ph Gabriel, Timmis, Adam, Yildirir, Aylin, G. Montalescot, U. Sechtem, S. Achenbach, F. Andreotti, C. Arden, A. Budaj, R. Bugiardini, F. Crea, T. Cuisset, C. Di Mario, J. R. Ferreira, B. J. Gersh, A. K. Gitt, J.-S. Hulot, N. Marx, L. H. Opie, M. Pfisterer, E. Prescott, F. Ruschitzka, M. Sabate, R. Senior, D. P. Taggart, E. E. van der Wall, C. J. M. Vrint, J. L. Zamorano, H. Baumgartner, J. J. Bax, H. Bueno, V. Dean, C. Deaton, C. Erol, R. Fagard, R. Ferrari, D. Hasdai, A. W. Hoe, P. Kirchhof, J. Knuuti, P. Kolh, P. Lancellotti, A. Linhart, P. Nihoyannopoulo, M. F. Piepoli, P. Ponikowski, P. A. Sirne, J. L. Tamargo, M. Tendera, A. Torbicki, W. Wijn, S. Windecker, M. Valgimigli, M. J. Claey, N. Donner-Banzhoff, H. Frank, C. Funck-Brentano, O. Gaemperli, J. R. Gonzalez-Juanatey, M. Hamilo, S. Husted, S. K. Jame, K. Kervinen, S. D. Kristensen, A. P. Maggioni, A. R. Prie, F. Romeo, L. Ryden, M. L. Simoon, P. G. Steg, A. Timmi, A. Yildirir, University of Zurich, and Montalescot, G
- Subjects
Male ,medicine.medical_specialty ,Acute coronary syndrome ,Cardiotonic Agents ,Angina pectoris ,anti-ischaemic drugs ,medicine.medical_treatment ,610 Medicine & health ,Coronary Artery Disease ,Fractional flow reserve ,Myocardial ischaemia ,Coronary revascularization ,GUIDELINES ,Risk Assessment ,2705 Cardiology and Cardiovascular Medicine ,Angina ,Coronary artery disease ,Electrocardiography ,Coronary artery bypass surgery ,Percutaneous Coronary Intervention ,Internal medicine ,Myocardial Revascularization ,Humans ,Medicine ,Angina, Stable ,cardiovascular diseases ,Myocardial infarction ,Coronary Artery Bypass ,Aged ,Evidence-Based Medicine ,Primary Health Care ,business.industry ,Coronary flow reserve ,Percutaneous coronary intervention ,Prognosis ,medicine.disease ,Cardiac Imaging Techniques ,Risk factors ,CHRONIC STABLE ANGINA ,Settore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARE ,10209 Clinic for Cardiology ,Cardiology ,Stable coronary artery disease ,Female ,Cardiology and Cardiovascular Medicine ,business ,Risk Reduction Behavior - Abstract
99mTc : technetium-99m 201TI : thallium 201 ABCB1 : ATP-binding cassette sub-family B member 1 ABI : ankle-brachial index ACC : American College of Cardiology ACCF : American College of Cardiology Foundation ACCOMPLISH : Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension ACE : angiotensin converting enzyme ACIP : Asymptomatic Cardiac Ischaemia Pilot ACS : acute coronary syndrome ADA : American Diabetes Association ADP : adenosine diphosphate AHA : American Heart Association ARB : angiotensin II receptor antagonist ART : Arterial Revascularization Trial ASCOT : Anglo-Scandinavian Cardiac Outcomes Trial ASSERT : Asymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial AV : atrioventricular BARI 2D : Bypass Angioplasty Revascularization Investigation 2 Diabetes BEAUTIFUL : Morbidity-Mortality Evaluation of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease and Left Ventricular Dysfunction BIMA : bilateral internal mammary artery BMI : body mass index BMS : bare metal stent BNP : B-type natriuretic peptide BP : blood pressure b.p.m. : beats per minute CABG : coronary artery bypass graft CAD : coronary artery disease CAPRIE : Clopidogrel vs. Aspirin in Patients at Risk of Ischaemic Events CASS : Coronary Artery Surgery Study CCB : calcium channel blocker CCS : Canadian Cardiovascular Society CFR : coronary flow reserve CHARISMA : Clopidogrel for High Atherothrombotic Risk and Ischaemic Stabilization, Management and Avoidance CI : confidence interval CKD : chronic kidney disease CKD-EPI : Chronic Kidney Disease Epidemiology Collaboration CMR : cardiac magnetic resonance CORONARY : The CABG Off or On Pump Revascularization Study COURAGE : Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation COX-1 : cyclooxygenase-1 COX-2 : cyclooxygenase-2 CPG : Committee for Practice Guidelines CT : computed tomography CTA : computed tomography angiography CV : cardiovascular CVD : cardiovascular disease CXR : chest X-ray CYP2C19*2 : cytochrome P450 2C19 CYP3A : cytochrome P3A CYP3A4 : cytochrome P450 3A4 CYP450 : cytochrome P450 DANAMI : Danish trial in Acute Myocardial Infarction DAPT : dual antiplatelet therapy DBP : diastolic blood pressure DECOPI : Desobstruction Coronaire en Post-Infarctus DES : drug-eluting stents DHP : dihydropyridine DSE : dobutamine stress echocardiography EACTS : European Association for Cardiothoracic Surgery EECP : enhanced external counterpulsation EMA : European Medicines Agency EASD : European Association for the Study of Diabetes ECG : electrocardiogram Echo : echocardiogram ED : erectile dysfunction EF : ejection fraction ESC : European Society of Cardiology EXCEL : Evaluation of XIENCE PRIME or XIENCE V vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization FAME : Fractional Flow Reserve vs. Angiography for Multivessel Evaluation FDA : Food & Drug Administration (USA) FFR : fractional flow reserve FREEDOM : Design of the Future Revascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease GFR : glomerular filtration rate HbA1c : glycated haemoglobin HDL : high density lipoprotein HDL-C : high density lipoprotein cholesterol HR : hazard ratio HRT : hormone replacement therapy hs-CRP : high-sensitivity C-reactive protein HU : Hounsfield units ICA : invasive coronary angiography IMA : internal mammary artery IONA : Impact Of Nicorandil in Angina ISCHEMIA : International Study of Comparative Health Effectiveness with Medical and Invasive Approaches IVUS : intravascular ultrasound JSAP : Japanese Stable Angina Pectoris KATP : ATP-sensitive potassium channels LAD : left anterior descending LBBB : left bundle branch block LIMA : Left internal mammary artery LDL : low density lipoprotein LDL-C : low density lipoprotein cholesterol LM : left main LMS : left main stem LV : left ventricular LVEF : left ventricular ejection fraction LVH : left ventricular hypertrophy MACE : major adverse cardiac events MASS : Medical, Angioplasty, or Surgery Study MDRD : Modification of Diet in Renal Disease MERLIN : Metabolic Efficiency with Ranolazine for Less Ischaemia in Non-ST-Elevation Acute Coronary Syndromes MERLIN-TIMI 36 : Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes: Thrombolysis In Myocardial Infarction MET : metabolic equivalents MI : myocardial infarction MICRO-HOPE : Microalbuminuria, cardiovascular and renal sub-study of the Heart Outcomes Prevention Evaluation study MPI : myocardial perfusion imaging MRI : magnetic resonance imaging NO : nitric oxide NSAIDs : non-steroidal anti-inflammatory drugs NSTE-ACS : non-ST-elevation acute coronary syndrome NYHA : New York Heart Association OAT : Occluded Artery Trial OCT : optical coherence tomography OMT : optimal medical therapy PAR-1 : protease activated receptor type 1 PCI : percutaneous coronary intervention PDE5 : phosphodiesterase type 5 PES : paclitaxel-eluting stents PET : positron emission tomography PRECOMBAT : Premier of Randomized Comparison of Bypass Surgery vs. Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease PTP : pre-test probability PUFA : polyunsaturated fatty acid PVD : peripheral vascular disease QoL : quality of life RBBB : right bundle branch block REACH : Reduction of Atherothrombosis for Continued Health RITA-2 : Second Randomized Intervention Treatment of Angina ROOBY : Veterans Affairs Randomized On/Off Bypass SAPT : single antiplatelet therapy SBP : systolic blood pressure SCAD : stable coronary artery disease SCORE : Systematic Coronary Risk Evaluation SCS : spinal cord stimulation SES : sirolimus-eluting stents SIMA : single internal mammary artery SPECT : single photon emission computed tomography STICH : Surgical Treatment for Ischaemic Heart Failure SWISSI II : Swiss Interventional Study on Silent Ischaemia Type II SYNTAX : SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery TC : total cholesterol TENS : transcutaneous electrical neural stimulation TERISA : Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina TIME : Trial of Invasive vs. Medical therapy TIMI : Thrombolysis In Myocardial Infarction TMR : transmyocardial laser revascularization TOAT : The Open Artery Trial WOEST : What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing Guidelines summarize and evaluate all evidence available, at the time of the writing process, on a particular issue with the aim of assisting physicians in selecting the best management strategies for an individual patient with a given condition, taking into account the impact on outcome, as well …
- Published
- 2013
20. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)
- Author
-
Brignole, Michele, Auricchio, Angelo, Baron-Esquivias, Gonzalo, Bordachar, Pierre, Boriani, Giuseppe, Breithardt, Ole-A, Cleland, John, Deharo, Jean-Claude, Delgado, Victoria, Elliott, Perry M, Gorenek, Bulent, Israel, Carsten W, Leclercq, Christophe, Linde, Cecilia, Mont, Lluís, Padeletti, Luigi, Sutton, Richard, Vardas, Panos E, Zamorano, Jose Luis, Achenbach, Stephan, Baumgartner, Helmut, Bax, Jeroen J, Bueno, Héctor, Dean, Veronica, Deaton, Christi, Erol, Cetin, Fagard, Robert, Ferrari, Roberto, Hasdai, David, Hoes, Arno W, Kirchhof, Paulus, Knuuti, Juhani, Kolh, Philippe, Lancellotti, Patrizio, Linhart, Ales, Nihoyannopoulos, Petros, Piepoli, Massimo F, Ponikowski, Piotr, Sirnes, Per Anton, Tamargo, Juan Luis, Tendera, Michal, Torbicki, Adam, Wijns, William, Windecker, Stephan, Blomstrom-Lundqvist, Carina, Badano, Luigi P, Aliyev, Farid, Bänsch, Dietmar, Bsata, Walid, Buser, Peter, Charron, Philippe, Daubert, Jean-Claude, Dobreanu, Dan, Faerestrand, Svein, Le Heuzey, Jean-Yves, Mavrakis, Hercules, McDonagh, Theresa, Merino, Jose Luis, Nawar, Mostapha M, Nielsen, Jens Cosedis, Pieske, Burkert, Poposka, Lidija, Ruschitzka, Frank, Van Gelder, Isabelle C, Wilson, Carol M, University of Zurich, Brignole, Michele, Department of Cardiology, Ospedali del Tigullio, CHU Bordeaux [Bordeaux], Service de cardiologie, Université de la Méditerranée - Aix-Marseille 2-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Cardiology, Karolinska University Hospital, Karolinska Institutet [Stockholm], Cardiology Department, University of Barcelona, European Society of Cardiology (ESC) - European Heart Rhythm Association (EHRA), M. Brignole, A. Auricchio, G. Baron-Esquivia, P. Bordachar, G. Boriani, O.-A. Breithardt, J. Cleland, J.-C. Deharo, V. Delgado, P. M. Elliott, B. Gorenek, C. W. Israel, C. Leclercq, C. Linde, L. Mont, L. Padeletti, R. Sutton, P. E. Varda, J. L. Zamorano, S. Achenbach, H. Baumgartner, J. J. Bax, H. Bueno, V. Dean, C. Deaton, C. Erol, R. Fagard, R. Ferrari, D. Hasdai, A. W. Hoe, P. Kirchhof, J. Knuuti, P. Kolh, P. Lancellotti, A. Linhart, P. Nihoyannopoulo, M. F. Piepoli, P. Ponikowski, P. A. Sirne, J. L. Tamargo, M. Tendera, A. Torbicki, W. Wijn, S. Windecker, C. Blomstrom-Lundqvist, L. P. Badano, F. Aliyev, D. Bansch, W. Bsata, P. Buser, P. Charron, J.-C. Daubert, D. Dobreanu, S. Faerestrand, J.-Y. Le Heuzey, H. Mavraki, T. McDonagh, J. L. Merino, M. M. Nawar, J. C. Nielsen, B. Pieske, L. Poposka, F. Ruschitzka, I. C. Van Gelder, C. M. Wilson, Université de Rennes 1 (UR1), and Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
medicine.medical_treatment ,Heart Valve Diseases ,Myocardial Infarction ,030204 cardiovascular system & hematology ,Ventricular tachycardia ,0302 clinical medicine ,2737 Physiology (medical) ,Bicuspid Aortic Valve Disease ,[INFO.INFO-TS]Computer Science [cs]/Signal and Image Processing ,Pregnancy ,Secondary Prevention ,030212 general & internal medicine ,Child ,ComputingMilieux_MISCELLANEOUS ,Heart Valve Prosthesis Implantation ,Cardiac resynchronization therapy ,Cardiac Pacing, Artificial ,Atrial fibrillation ,Implantable cardioverter-defibrillator ,Magnetic Resonance Imaging ,3. Good health ,Defibrillators, Implantable ,Europe ,Pacemaker ,Aortic Valve ,Cardiology ,Catheter Ablation ,cardiovascular system ,Female ,[SDV.IB]Life Sciences [q-bio]/Bioengineering ,Cardiology and Cardiovascular Medicine ,[SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing ,Algorithms ,Heart Defects, Congenital ,Reoperation ,medicine.medical_specialty ,Prosthesis-Related Infections ,Defibrillation ,Pregnancy Complications, Cardiovascular ,Heart failure ,610 Medicine & health ,Syncope ,11171 Cardiocentro Ticino ,2705 Cardiology and Cardiovascular Medicine ,Sick sinus syndrome ,03 medical and health sciences ,Rare Diseases ,Internal medicine ,Physiology (medical) ,medicine ,Bradycardia ,Humans ,cardiovascular diseases ,Emergency Treatment ,Postoperative Care ,business.industry ,Contraindications ,Remote Consultation ,Arrhythmias, Cardiac ,Stroke Volume ,Cardiomyopathy, Hypertrophic ,ta3121 ,medicine.disease ,Cardiac pacing ,Ventricular fibrillation ,Heart Transplantation ,business - Abstract
Abbreviations 1st AV : First-degree atrioventricular block AF : atrial fibrillation AT : atrial tachyarrhythmia ATP : Anti-tachycardia pacing AV : atrioventricular BBB : bundle branch block CHF : congestive heart failure CI : confidence interval CPG : Committee for Practice Guidelines CRT : cardiac resynchronization therapy CRT-D : cardiac resynchronization therapy and defibrillator CRT-P : cardiac resynchronization therapy and pacemaker ECG : electrocardiogram EDMD : Emery-Dreifuss muscular dystrophy EF : ejection fraction EPS : electrophysiological study ESC : European Society of Cardiology HCM : hypertrophic cardiomyopathy HF : heart failure HR : hazard ratio HV : His-ventricular ICD : implantable cardioverter defibrillator ILR : implantable loop recorder IVCD : intraventricular conduction delay LBBB : left bundle branch block LQTS : long QT syndrome LV : left ventricular LVEF : left ventricular ejection fraction LVSD : left ventricular systolic dysfunction MR : mitral regurgitation MRI : magnetic resonance imaging NYHA : New York Heart Association PM : pacemaker OR : odds ratio QALY : quality-adjusted life year RBBB : right bundle branch block RCT : randomized controlled trial RV : right ventricular SB : sinus bradycardia SNRT : sinus node recovery time SR : sinus rhythm SSS : sick sinus syndrome TAVI : transcatheter aortic valve implantation VF : ventricular fibrillation VT : ventricular tachycardia VV : interventricular (delay) ### Acronyms of the trials referenced in the recommendations or reported in the tables ADEPT : ADvanced Elements of Pacing Randomized Controlled Trial ADOPT : Atrial Dynamic Overdrive Pacing Trial AOPS : Atrial Overdrive Pacing Study APAF : Ablate and Pace in Atrial Fibrillation ASSERT : ASymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial ATTEST : ATrial Therapy Efficacy and Safety Trial AVAIL CLS/CRT : AV Node Ablation with CLS and CRT Pacing Therapies for Treatment of AF trial B4 : Bradycardia detection in Bundle Branch Block BELIEVE : Bi vs. Left Ventricular Pacing: an International Pilot Evaluation on Heart Failure Patients with Ventricular Arrhythmias BIOPACE : Biventricular pacing for atrioventricular block to prevent cardiac desynchronization BLOCK-HF : Biventricular versus right ventricular pacing in patients with AV block B-LEFT : Biventricular versus LEFT Univentricular Pacing with ICD Back-up in Heart Failure Patients CARE-HF : CArdiac REsynchronization in Heart Failure CLEAR : CLinical Evaluation on Advanced Resynchronization COMBAT : COnventional vs. Biventricular Pacing in Heart Failure and Bradyarrhythmia COMPANION : COmparison of Medical Therapy, Pacing and Defibrillation in Heart Failure DANPACE : DANish Multicenter Randomized Trial on Single Lead Atrial PACing vs. Dual Chamber Pacing in Sick Sinus Syndrome DECREASE-HF : The Device Evaluation of CONTAK RENEWAL 2 and EASYTRAK 2: Assessment of Safety and Effectiveness in Heart Failure FREEDOM : Optimization Study Using the QuickOpt Method GREATER-EARTH : Evaluation of Resynchronization Therapy for Heart Failure in Patients with a QRS Duration GREATER Than 120 ms LESSER-EARTH : Evaluation of Resynchronization Therapy for Heart Failure in Patients with a QRS Duration Lower Than 120 ms HOBIPACE : HOmburg BIventricular PACing Evaluation IN-CHF : Italian Network on Congestive Heart Failure ISSUE : International Study on Syncope of Unexplained Etiology MADIT : Multicenter Automatic Defibrillator Trial MIRACLE : Multicenter InSync RAndomized CLinical Evaluation MOST : MOde Selection Trial in Sinus-Node Dysfunction MUSTIC : MUltisite STimulation In Cardiomyopathies OPSITE : Optimal Pacing SITE PACE : Pacing to Avoid Cardiac Enlargement PAVE : Left Ventricular-Based Cardiac Stimulation Post AV Nodal Ablation Evaluation PATH-CHF : PAcing THerapies in Congestive Heart Failure II Study Group PIPAF : Pacing In Prevention of Atrial Fibrillation Study PIRAT : Prevention of Immediate Reinitiation of Atrial Tachyarrhythmias POT : Prevention Or Termination Study PREVENT-HF : PREventing VENTricular Dysfunction in Pacemaker Patients Without Advanced Heart Failure PROSPECT : PRedictors Of Response to Cardiac Resynchronization Therapy RAFT : Resynchronization–Defibrillation for Ambulatory Heart Failure Trial RethinQ : Cardiac REsynchronization THerapy IN Patients with Heart Failure and Narrow QRS REVERSE : REsynchronization reVErses Remodelling in Systolic left vEntricular dysfunction SAFARI : Study of Atrial Fibrillation Reduction SCD HeFT : Sudden Cardiac Death in Heart Failure Trial SMART-AV : The SMARTDelay Determined AV Optimization: a Comparison with Other AV Delay Methods Used in Cardiac Resynchronization Therapy SYDIT : The SYncope DIagnosis and Treatment SYNPACE : Vasovagal SYNcope and PACing TARGET : TARgeted Left Ventricular Lead Placement to Guide Cardiac Resynchronization Therapy THEOPACE : Effects of Oral THEOphylline and of Permanent PACEmaker on the Symptoms and Complications of Sick Sinus Syndrome VASIS-PM : VAsovagal Syncope International Study on PaceMaker therapy V-HeFT : Vasodilator in HEart Failure Trial VPSII : Second Vasovagal Pacemaker Study (VPS II) Additional references are mentioned with ‘w’ in the main text and can be found on the online addenda along with 5 figures (1, 6, 7, 9, 11, 12) and 10 tables (3, 4, 5, 9, 11, 12, 19, 21, 22, 23). They are available on the ESC website only at http://www.escardio.org/guidelines-surveys/esc-guidelines/Pages/cardiac-pacing-and-cardiac-resynchronisation-therapy.aspx Guidelines summarize and evaluate all available evidence, at the time of the writing process, on a …
- Published
- 2013
21. 2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases
- Author
-
Adler, Yehuda, Charron, Philippe, Imazio, Massimo, Badano, Luigi, Barón Esquivias, Gonzalo, Bogaert, Jan, Brucato, Antonio, Gueret, Pascal, Klingel, Karin, Lionis, Christos, Maisch, Bernhard, Mayosi, Bongani, Pavie, Alain, Ristić, Arsen D., Tenas, Manel Sabaté, Seferovic, Petar, Swedberg, Karl, Tomkowski, Witold, Achenbach, Stephan, Agewall, Stefan, Al Attar, Nawwar, Ferrer, Juan Angel, Arad, Michael, Asteggiano, Riccardo, Bueno, Héctor, Caforio, Alida L. P., Carerj, Scipione, Ceconi, Claudio, Evangelista, Arturo, Flachskampf, Frank, Giannakoulas, George, Gielen, Stephan, Habib, Gilbert, Kolh, Philippe, Lambrinou, Ekaterini, Lancellotti, Patrizio, Lazaros, George, Linhart, Ales, Meurin, Philippe, Nieman, Koen, Piepoli, Massimo F., Price, Susanna, Roos Hesselink, Jolien, Zamorano, Jose Luis, Aboyans, Victor, Badimon, Lina, Baumgartner, Helmut, Bax, Jeroen J., Dean, Veronica, Erol, Cetin, Fitzimons, Donna, Gaemperli, Oliver, Kirchhof, Paulus, Lip, Gregory Y. H., Nihoyannopoulos, Petros, Ponikowski, Piotr, Roffi, Marco, Torbicki, Adam, Carneiro, Antonio Vaz, Windecker, Stephan, Adler, Y, Charron, P, Imazio, M, Badano, L, Baron-Esquivias, G, Bogaert, J, Brucato, A, Gueret, P, Klingel, K, Lionis, C, Maisch, B, Mayosi, B, Pavie, A, Ristic, A, Tenas, M, Seferovic, P, Swedberg, K, Tomkowski, W, Achenbach, S, Agewall, S, Al-Attar, N, Ferrer, J, Arad, M, Asteggiano, R, Bueno, H, Caforio, A, Carerj, S, Ceconi, C, Evangelista, A, Flachskampf, F, Giannakoulas, G, Gielen, S, Habib, G, Kolh, P, Lambrinou, E, Lancellotti, P, Lazaros, G, Linhart, A, Meurin, P, Nieman, K, Piepoli, M, Price, S, Roos-Hesselink, J, Zamorano, J, Aboyans, V, Badimon, L, Baumgartner, H, Bax, J, Dean, V, Erol, C, Fitzimons, D, Gaemperli, O, Kirchhof, P, Lip, G, Nihoyannopoulos, P, Ponikowski, P, Roffi, M, Torbicki, A, Carneiro, A, and Windecker, S
- Subjects
Male ,Cardiac Catheterization ,Pathology ,Multimodal Imaging ,Heart Neoplasms ,Kidney Failure ,Pericarditis ,Myocardial infarction ,Aetiology ,Chronic ,Tomography ,Societies, Medical ,Pericardiocentesis ,General Medicine ,Constrictive pericarditis ,Diagnosis ,Guidelines ,Myopericarditis ,Pericardial effusion ,Pericardium ,Prognosis ,Tamponade ,Therapy ,Cardiothoracic surgery ,Echocardiography ,Acute Disease ,Pericardial diseases ,cardiovascular system ,Drainage ,Antibody ,Cardiology and Cardiovascular Medicine ,medicine.medical_specialty ,Congenital cytomegalovirus infection ,Guidelines, Aetiology, Constrictive pericarditis, Diagnosis, Myopericarditis, Pericardial effusion, Pericardiocentesis, Pericarditis, Pericardium, Prognosis, Tamponade, Therapy ,Text mining ,Humans ,Radiation Injuries ,Physical Examination ,medicine.disease ,Cardiac Tamponade ,Heart Injuries ,chemistry ,Positron-Emission Tomography ,Kidney Failure, Chronic ,Creatine kinase ,Triage ,Biomarkers ,Magnetic Resonance Angiography ,Biopsy ,Basic fibroblast growth factor ,Anti-Inflammatory Agents ,Medical and Health Sciences ,chemistry.chemical_compound ,Postoperative Complications ,Adenosine deaminase ,Recurrence ,reproductive and urinary physiology ,Age Factors ,Autoimmune Diseases ,Bacterial Infections ,Chronic Disease ,Endoscopy ,Hospitalization ,Sex Factors ,Syndrome ,Tomography, X-Ray Computed ,Treatment Outcome ,Virus Diseases ,Pericardial Effusion ,biology ,Medicine (all) ,Thoracic Surgery ,X-Ray Computed ,Europe ,medicine.anatomical_structure ,Infective endocarditis ,embryonic structures ,Cardiology ,Female ,biological phenomena, cell phenomena, and immunity ,Esc Guidelines ,Heart Diseases ,Acute pericarditis ,Internal medicine ,medicine ,Diseases of the circulatory (Cardiovascular) system ,cardiovascular diseases ,urogenital system ,Task force ,business.industry ,RC666-701 ,biology.protein ,business - Abstract
ADA : adenosine deaminase AMI : acute myocardial infarction ANA : anti-nuclear antibody bFGF : basic fibroblast growth factor CK : creatine kinase CMR : cardiac magnetic resonance CMV : cytomegalovirus CP : Child–Pugh CRP : C-reactive protein CT : computed tomography EBV
- Published
- 2015
22. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
- Author
-
European Association, for Percutaneous Cardiovascular Interventions, Wijns, William, Kolh, Philippe, Danchin, Nicolas, Di Mario, Carlo, Falk, Volkmar, Folliguet, Thierry, Garg, Scot, Huber, Kurt, James, Stefan, Knuuti, Juhani, Lopez-Sendon, Jose, Marco, Jean, Menicanti, Lorenzo, Ostojic, Miodrag, Piepoli, Massimo F, Pirlet, Charles, Pomar, Jose L, Reifart, Nicolaus, Ribichini, Flavio L, Schalij, Martin J, Sergeant, Paul, Serruys, Patrick W, Silber, Sigmund, Sousa Uva, Miguel, Taggart, David, ESC Committee, for Practice Guidelines, Vahanian, Alec, Auricchio, Angelo, Bax, Jeroen, Ceconi, Claudio, Dean, Veronica, Filippatos, Gerasimos, Funck-Brentano, Christian, Hobbs, Richard, Kearney, Peter, McDonagh, Theresa, Popescu, Bogdan A, Reiner, Zeljko, Sechtem, Udo, Sirnes, Per Anton, Tendera, Michal, Vardas Panos, E, Widimsky, Petr, EACTS Clinical Guidelines, Committee, Alfieri, Ottavio, Dunning, Joel, Elia, Stefano, Kappetein, Pieter, Lockowandt, Ulf, Sarris, George, Vouhe, Pascal, von Segesser, Ludwig, Agewall, Stefan, Aladashvili, Alexander, Alexopoulos, Dimitrios, Antunes, Manuel J, Atalar, Enver, Brutel de la Riviere, Aart, Doganov, Alexander, Eha, Jaan, Fajadet, Jean, Ferreira, Rafael, Garot, Jerome, Halcox, Julian, Hasin, Yonathan, Janssens, Stefan, Kervinen, Kari, Laufer, Gunther, Legrand, Victor, Nashef Samer, A M, Neumann, Franz-Josef, Niemela, Kari, Nihoyannopoulos, Petros, Noc, Marko, Piek, Jan J, Pirk, Jan, Rozenman, Yoseph, Sabate, Manel, Starc, Radovan, Thielmann, Matthias, Wheatley, David J, Windecker, Stephan, and Zembala, Marian
- Subjects
myocardial ,revascularization ,medicine.medical_specialty ,business.industry ,Judgement ,Medizin ,MEDLINE ,Conflict of interest ,EuroSCORE ,Evidence-based medicine ,medicine.disease ,Coronary artery bypass surgery ,Cardiothoracic surgery ,Internal medicine ,medicine ,Cardiology ,Medical emergency ,Cardiology and Cardiovascular Medicine ,Risk assessment ,business - Abstract
Guidelines and Expert Consensus Documents summarize and evaluate all available evidence with the aim of assisting physicians in selecting the best management strategy for an individual patient suffering from a given condition, taking into account the impact on outcome and the risk–benefit ratio of diagnostic or therapeutic means. Guidelines are no substitutes for textbooks and their legal implications have been discussed previously. Guidelines and recommendations should help physicians to make decisions in their daily practice. However, the ultimate judgement regarding the care of an individual patient must be made by his/her responsible physician(s). The recommendations for formulating and issuing ESC Guidelines and Expert Consensus Documents can be found on the ESC website (http://www.escardio.org/knowledge/guidelines/rules). Members of this Task Force were selected by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) to represent all physicians involved with the medical and surgical care of patients with coronary artery disease (CAD). A critical evaluation of diagnostic and therapeutic procedures is performed including assessment of the risk–benefit ratio. Estimates of expected health outcomes for society are included, where data exist. The level of evidence and the strength of recommendation of particular treatment options are weighed and graded according to predefined scales, as outlined in Tables 1 and 2 . View this table: Table 1 Classes of recommendations View this table: Table 2 Levels of evidence The members of the Task Force have provided disclosure statements of all relationships that might be perceived as real or potential sources of conflicts of interest. These disclosure forms are kept on file at European Heart House, headquarters of the ESC. Any changes in conflict of interest that arose during the writing period were notified to the ESC. The Task Force report received its entire financial support from the ESC and EACTS, without any involvement of the pharmaceutical, device, or surgical industry. ESC …
- Published
- 2010
- Full Text
- View/download PDF
23. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer
- Author
-
Renseigné, Non, Habib, Gilbert, Hoen, Bruno, Tornos, Pilar, Thuny, Franck, Prendergast, Bernard, Vilacosta, Isidre, Moreillon, Philippe, De Jesus Antunes, Manuel, Thilen, Ulf, Lekakis, John, Lengyel, Maria, Müller, Ludwig, Naber, Christoph K, Nihoyannopoulos, Petros, Moritz, Anton, Zamorano, Jose Luis, Vahanian, Alec, Auricchio, Angelo, Bax, Jeroen, Ceconi, Claudio, Dean, Veronica, Filippatos, Gerasimos, Funck-Brentano, Christian, Hobbs, Richard, Kearney, Peter, Mcdonagh, Theresa, Mcgregor, Keith, Popescu, Bogdan A, Reiner, Zeljko, Sechtem, Udo, Sirnes, Per Anton, Tendera, Michal, Vardas, Panos, Widimsky, Petr, Aguilar, Rio, Bongiorni, Maria Grazia, Borger, Michael, Butchart, Eric, Danchin, Nicolas, Delahaye, François, Erbel, Raimund, Franzen, Damian, Gould, Kate, Hall, Roger, Hassager, Christian, Kjeldsen, Keld, Mcmanus, Richard, Miró, José M, Mokracek, Ales, Rosenhek, Raphael, San Román Calvar, José A, Seferovic, Petar, Selton-Suty, Christine, Uva, Miguel Sousa, Trinchero, Rita, Van Camp, Guy, Service des maladies infectieuses et tropicales, Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Hôpital Saint-Jacques, Laboratoire Chrono-environnement ( LCE ), Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC ) -Centre National de la Recherche Scientifique ( CNRS ), Service de cardiologie, Assistance publique - Hôpitaux de Paris (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris]-Université Paris Diderot - Paris 7 ( UPD7 ), Service de pharmacologie - Dosage de médicaments [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Saint-Antoine [APHP], CIC Saint-Antoine, Assistance publique - Hôpitaux de Paris (AP-HP)-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -CHU Saint-Antoine [APHP], Department of Earth Science, University of Durham, Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Hôpital Saint-Jacques, Laboratoire Chrono-environnement - CNRS - UBFC (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Université Paris Diderot - Paris 7 (UPD7)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Durham University, Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon)-Hôpital Saint-Jacques, Laboratoire Chrono-environnement - UFC (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Université Paris Diderot - Paris 7 (UPD7)-AP-HP - Hôpital Bichat - Claude Bernard [Paris]-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Saint-Antoine [APHP], and Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Saint-Antoine [APHP]
- Subjects
media_common.quotation_subject ,MEDLINE ,Cardiology ,030204 cardiovascular system & hematology ,Health outcomes ,03 medical and health sciences ,0302 clinical medicine ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,medicine ,Humans ,Quality (business) ,030212 general & internal medicine ,ComputingMilieux_MISCELLANEOUS ,Societies, Medical ,media_common ,Medical education ,Endocarditis ,business.industry ,Conflict of interest ,Evidence-based medicine ,medicine.disease ,3. Good health ,Europe ,[ SDV.MHEP.MI ] Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Order (business) ,Infective endocarditis ,Table (database) ,Cardiology and Cardiovascular Medicine ,business - Abstract
Guidelines and Expert Consensus Documents summarize and evaluate all currently available evidence on a particular issue with the aim of assisting physicians in selecting the best management strategy for an individual patient suffering from a given condition, taking into account the impact on outcome, as well as the risk/benefit ratio of particular diagnostic or therapeutic means. Guidelines are no substitutes for textbooks. The legal implications of medical guidelines have been discussed previously. A great number of Guidelines and Expert Consensus Documents have been issued in recent years by the European Society of Cardiology (ESC) as well as by other societies and organizations. Because of the impact on clinical practice, quality criteria for development of guidelines have been established in order to make all decisions transparent to the user. The recommendations for formulating and issuing ESC Guidelines and Expert Consensus Documents can be found on the ESC website (http://www.escardio.org/knowledge/guidelines/rules). In brief, experts in the field are selected and undertake a comprehensive review of the published evidence for management and/or prevention of a given condition. A critical evaluation of diagnostic and therapeutic procedures is performed including assessment of the risk/ benefit ratio. Estimates of expected health outcomes for larger societies are included, where data exist. The level of evidence and the strength of recommendation of particular treatment options are weighed and graded according to predefined scales, as outlined in Tables 1 and 2 . View this table: Table 1 Classes of recommendations View this table: Table 2 Levels of evidence The experts of the writing panels have provided disclosure statements of all relationships they may have which might be perceived as real or potential sources of conflicts of interest. These disclosure forms are kept on file at the European Heart House, headquarters of the ESC. Any changes in conflict of interest that arise during the writing period must be notified to …
- Published
- 2009
24. Normal reference values of left ventricular strain using three-dimensional speckle tracking echocardiography: results from a multicentre study.
- Author
-
Kleijn, Sebastiaan A., Pandian, Natesa G., Thomas, James D., Perez de Isla, Leopoldo, Kamp, Otto, Zuber, Michel, Nihoyannopoulos, Petros, Forster, Tamas, Nesser, Hans-Joachim, Geibel, Annette, Gorissen, Willem, and Zamorano, Jose L.
- Subjects
HEART physiology ,LEFT heart ventricle ,LEFT ventricular hypertrophy ,ACADEMIC medical centers ,CARDIOLOGY ,DIAGNOSTIC imaging ,ECHOCARDIOGRAPHY ,ETHNIC groups ,RACE ,REFERENCE values ,WHITE people ,DATA analysis ,PATIENT selection ,DESCRIPTIVE statistics ,DIAGNOSIS ,ANATOMY - Abstract
Aims Three-dimensional (3D) speckle tracking echocardiography (3DSTE) has been shown to be an accurate and reliable clinical tool for the evaluation of global and regional left ventricular (LV) function through strain analysis, but the absence of normal values has precluded its widespread use in clinical practice. The aim of this prospective multicentre study was to establish normal reference values of LV strain parameters using 3DSTE in a large healthy population. Methods and results A total of 303 healthy subjects (156 males [51%], between 18 and 82 years of age, ejection fraction [EF] 61±3%), stratified to provide approximately equal proportions of healthy subjects of 18-30, 31-40, 41-50, 51-60, and >60 years of age, underwent 3DSTE. Data were analysed for LV volumes, EF, mass, and global and regional circumferential, longitudinal, radial, and area strain. Significant but small differences between men and women were found for longitudinal and area strains, as well as between different age groups for all LV strain parameters. However, large differences in normal values were observed between different segments, walls, and levels of the LV for radial and longitudinal strains, whereas circumferential and area strains demonstrated generally consistent normal ranges across the LV. Conclusions Normal ranges of global and regional LV strain using 3DSTE have been established for clinical use. Differences in the magnitude of LV strain are present between men and women as well as different age groups. Moreover, there are differences between different segments, walls, and levels as part of the functional non-uniformity of the normal LV that necessitates the use of segment-specific normal ranges for radial and longitudinal strains. Circumferential and area strains demonstrate the most consistent normal ranges overall. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
25. Myocardial Ischemia in Congenital Heart Disease: The Role of Noninvasive Imaging.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Bax, Jeroen J., Wall, Ernst, Tan, J. L., Loong, C. Y., Anagnostopoulos-Tzifa, A., Kilner, P. J., Li, W., and Gatzoulis, M. A.
- Published
- 2006
- Full Text
- View/download PDF
26. Myocardial Ischemia in Conditions Other Than Atheromatous Coronary Artery Disease.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Bax, Jeroen J., Wall, Ernst, Nagel, Eike, and Pettigrew, Roderic I.
- Published
- 2006
- Full Text
- View/download PDF
27. Imaging Techniques for Assessment of Viability and Hibernation.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Wall, Ernst, Schinkel, Arend F. L., Poldermans, Don, Elhendy, Abdou, and Bax, Jeroen J.
- Published
- 2006
- Full Text
- View/download PDF
28. Role of Stress Imaging Techniques in Evaluation of Patients Before and after Myocardial Revascularization.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Bax, Jeroen J., Wall, Ernst, and Elhendy, Abdou
- Abstract
Stress echocardiography and MPS are clinically useful tools for selection of patients with known or suspected CAD who are likely to benefit from revascularization. Both imaging modalities are the mainstay tests for the diagnosis of in-stent stenosis and graft disease and are integral parts of the investigative strategies recommended by both European and American guidelines. However, CMR and multislice computed tomography are increasingly used for this purpose in centers with access to these techniques. Myocardial perfusion and wall motion abnormalities after myocardial revascularization are predictive of cardiac events and the risk associated with these abnormalities is not related to symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
29. Imaging in the Emergency Department or Chest Pain Unit.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Bax, Jeroen J., Wall, Ernst, Soman, Prem, and Udelson, James E.
- Abstract
The assessment and triage of ED patients with suspected ACS is a process that requires considerations of clinical risk, patient safety, and cost-effectiveness. The strategies used should be highly sensitive to minimize the chances of missing the diagnosis of ACS. The noninvasive modalities of MPI and echocardiography have suitable characteristics. Data on MPI predominate in the literature, with prospective, randomized studies demonstrating applicability, safety, and cost-effectiveness, such that ED MPI for evaluation of suspected ACS has attained a class I, level A indication in the US. In the future, imaging of ischemic memory using fatty acid analogs such as BMIPP may further enhance the utility of radionuclide imaging in this setting. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
30. Risk Stratification after Acute Coronary Syndromes.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Bax, Jeroen J., Wall, Ernst, and Beller, George A.
- Published
- 2006
- Full Text
- View/download PDF
31. Prognostic Assessment by Noninvasive Imaging. Part b. Risk Assessment Before Noncardiac Surgery by Noninvasive Imaging.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Bax, Jeroen J., Wall, Ernst, Schouten, Olaf, Kertai, Miklos D., and Poldermans, Don
- Abstract
1.Preoperative cardiac evaluation of patients undergoing surgery offers the possibility of reducing cardiac risk by treating myocardial ischemia, hypertension, and hyperlipidemia. This will reduce perioperative risk and improve long-term outcome.2.Patients without predictors of cardiac events are at low risk even if undergoing intermediate- or high-risk surgery. Patients with one or more predictors (e.g., angina pectoris class I or II, previous MI, diabetes mellitus, compensated or prior congestive heart failure, important cardiac arrhythmias) who are undergoing low-or intermediate-risk surgery do not benefit from additional investigation (unless their functional capacity is poor), because the risk of perioperative events is low. However, both groups will benefit from beta-blockade.3.Noninvasive imaging should further assess the perioperative risk in patients with multiple predictors undergoing high-risk surgery. MPS and dobutamine echocardiography have comparable accuracy and the choice of test should be that in which the center has the most experience. Accurate assessment of the ischemic burden is helpful to predict perioperative risk but simultaneous assessment of the LV function, by means of ECG gated SPECT in the case of MPS, could be helpful in the long-term evaluation of the cardiac risk.4.Patients with mild to moderate inducible ischemia should be managed as they would be in the absence of peripheral vascular surgery, and they should receive beta-blockers before, during, and after surgery. In patients with extensive inducible ischemia, the cardioprotective effect of beta-blockers is probably insufficient and referral to coronary angiography should be considered. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
32. Prognostic Assessment by Noninvasive Imaging. Part a. Clinical Decision-making in Patients with Suspected or Known Coronary Artery Disease.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Bax, Jeroen J., Wall, Ernst, Hachamovitch, Rory, Shaw, Leslee J., and Berman, Daniel S.
- Published
- 2006
- Full Text
- View/download PDF
33. Diagnosis of Coronary Artery Disease.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Bax, Jeroen J., Wall, Ernst, Reyes, Eliana, Bunce, Nicholas, and Senior, Roxy
- Published
- 2006
- Full Text
- View/download PDF
34. Noninvasive Assessment of Asymptomatic Individuals at Risk of Coronary Heart Disease. Part b.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Bax, Jeroen J., Wall, Ernst, Rakhit, Dhrubo, and Marwick, Thomas H.
- Abstract
Echocardiography provides useful information for high-risk asymptomatic patients. When combined with stress, a powerful prognostic tool is available that can unmask previously undiagnosed CAD. The application of this to screening is constrained by overall low disease probability in unselected asymptomatic patients, but the use of clinical tools, such as the Framingham risk score, can define a subgroup, which will be enriched with high-risk individuals. We have examined the role of SE and other imaging modalities in various high-risk subgroups. Overall, SE seems to have a good predictive value comparable to that of MPS and in certain cases may avoid the need for coronary angiography. For those who have abnormalities on a noninvasive imaging test and are asymptomatic, a management plan needs to be defined. This includes a choice of addressing cardiac risk factors, or invasive assessment of coronary anatomy by angiography with a view to possible revascularization if necessary. In many of the high-risk subgroups we have discussed, the decision to proceed to revascularization is hampered by the lack of large randomized trials to support this approach. Although SE and MPS can provide prognostic data in high-risk subgroups, further clarification with multicenter studies is required to assess under what circumstances revascularization can alter prognosis in high-risk patients who are truly asymptomatic. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
35. Noninvasive Assessment of Asymptomatic Individuals at Risk of Coronary Heart Disease. Part a.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Bax, Jeroen J., Wall, Ernst, Lim, E. T. S., Anand, D. V., and Lahiri, A.
- Abstract
Cardiovascular risk estimates can be improved by several noninvasive imaging techniques, collectively called atherosclerosis imaging. Clinically useful techniques currently include coronary calcium imaging and carotid ultra sound. Both these tests are most valuable in intermediate-risk patients, in whom a significant proportion will be reassigned into either a higher- or lower-risk category. However, before widespread adoption of any of these techniques takes place, studies to establish treatment protocols based on atherosclerosis imaging tests and to determine the cost-effectiveness of atherosclerosis imaging tests are needed. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
36. Computed Tomography Techniques and Principles. Part b. Multislice Computed Tomography.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Bax, Jeroen J., Wall, Ernst, Feyter, P. J., Cademartiri, F., Mollet, N. R., and Nieman, K.
- Abstract
The ability of CT imaging to visualize and measure disease process in the coronary arteries has increased our knowledge of atherosclerosis and coronary heart disease. Beyond feasibility studies, further well-designed, prospective single or multicenter studies are required to assess the diagnostic performance of MS-CT in various patient populations with different levels of prevalence of coronary artery disease and to establish the diagnostic role of MS-CT in cardiology before we embrace this promising technique as a clinically acceptable new diagnostic tool. Moreover, the fundamental characteristics of MS-CT such as the X-Y spatial resolution, slice thickness, and temporal resolution need to be further optimized to consider MS-CT coronary angiography as a reliable clinical diagnostic tool to detect coronary atherosclerotic obstructions. In particular, the temporal resolution needs improvement to meet the challenges of motion-free imaging also during faster heart rates. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
37. Computed Tomography Techniques and Principles. Part a. Electron Beam Computed Tomography.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Bax, Jeroen J., Wall, Ernst, Mittal, Tarun K., and Rubens, Michael B.
- Abstract
EBCT is a highly sensitive technique for detection and measurement of coronary artery calcification and thus noninvasive estimation of atherosclerotic plaque burden. It offers a high spatial resolution with low acquisition time and has good reproducibility and interobserver agreement with optimized ECG triggering. EBCT is a mature technique for calcium detection with a continuously expanding literature. With growing technological advances, cardiac CT has a promising role in clinical practice as well as research. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
38. Positron Emission Tomography.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Bax, Jeroen J., Wall, Ernst, and Bengel, Frank M.
- Published
- 2006
- Full Text
- View/download PDF
39. Myocardial Perfusion Scintigraphy.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Bax, Jeroen J., Wall, Ernst, Flotats, Albert, and Carrió, Ignasi
- Published
- 2006
- Full Text
- View/download PDF
40. Cardiac Magnetic Resonance.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Bax, Jeroen J., Wall, Ernst, and Rademakers, Frank E.
- Published
- 2006
- Full Text
- View/download PDF
41. Echocardiography in Coronary Artery Disease.
- Author
-
Anagnostopoulos, Constantinos D., Bax, Jeroen J., Wall, Ernst, and Nihoyannopoulos, Petros
- Abstract
Echocardiography is an important tool for patients with CAD. It can be used to differentiate regional myocardial ischemia from other etiologies of chest pain, can be used to evaluate the extent of myocardial dysfunction, at rest and with stress, and to ascertain the presence of complications in patients with acute myocardial infarction. With the prospect of identifying myocardial perfusion defects, echocardiography is clearly an approach that can provide a "one-stop" strategy for assessing cardiac anatomy, function, and perfusion. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
42. Principles of Pathophysiology Related to Noninvasive Cardiac Imaging.
- Author
-
Anagnostopoulos, Constantinos D., Nihoyannopoulos, Petros, Bax, Jeroen J., Wall, Ernst, and Harbinson, Mark
- Abstract
The pathophysiology of myocardial ischemia involves a series of progressive changes from the cellular level through perfusion abnormalities, contractile dysfunction, electrocardiographic abnormalities, and finally symptoms. In clinical practice, it has multiple potential manifestations, with atherosclerotic coronary disease being the most important underlying etiology. Uncovering these abnormalities or their underlying causes requires selection of the most appropriate stress method depending on the question being asked, and the clinical status of the patient. A sound understanding of the principles of imaging will contribute to informed interpretation of test results. Only by integrating knowledge of the pathophysiology of myocardial ischemia, the role of the various stress modalities, and the strengths and weaknesses of the available imaging technologies will the best possible test be selected for each patient. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
43. Updated standards and processes for accreditation of echocardiographic laboratories from The European Association of Cardiovascular Imaging.
- Author
-
Popescu, Bogdan A., Stefanidis, Alexandros, Nihoyannopoulos, Petros, Fox, Kevin F., Ray, Simon, Cardim, Nuno, Rigo, Fausto, Badano, Luigi P., Fraser, Alan G., Pinto, Fausto, Zamorano, Jose Luis, Habib, Gilbert, Maurer, Gerald, and Lancellotti, Patrizio
- Subjects
HEART disease diagnosis ,CARDIOLOGY ,DIAGNOSTIC imaging ,ECHOCARDIOGRAPHY ,MEDICAL quality control ,MEDICAL societies ,ACCREDITATION - Abstract
Standards for echocardiographic laboratories were proposed by the European Association of Echocardiography (now the European Association of Cardiovascular Imaging) 7 years ago in order to raise standards of practice and improve the quality of care. Criteria and requirements were published at that time for transthoracic, transoesophageal, and stress echocardiography. This paper reassesses and updates the quality standards to take account of experience and the technical developments of modern echocardiographic practice. It also discusses quality control, the incentives for laboratories to apply for accreditation, the reaccreditation criteria, and the current status and future prospects of the laboratory accreditation process. [ABSTRACT FROM PUBLISHER]
- Published
- 2014
44. Ghidul ESC de diagnostic şi tratament al insuficienţei cardiace acute şi cronice 2016.
- Author
-
Ponikowski, Piotr, Voors, Adriaan A., Anker, Stefan D., Bueno, Héctor, Cleland, John G. F., Coats, Andrew J. S., Falk, Volkmar, González-Juanatey, José Ramón, Harjola, Veli-Pekka, Jankowska, Ewa A., Jessup, Mariell, Nihoyannopoulos, Petros, Parissis, John T., Pieske, Burkert, Riley, Jillian P., Rosano, Giuseppe M. C., Ruilope, Luis M., Ruschitzka, Frank, Rutten, Frans H., and van der Mee, Peter
- Subjects
- *
CARDIOLOGY , *CARDIAC magnetic resonance imaging , *DIABETES conferences - Published
- 2017
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.